Amgen cholesterol drug cuts heart attack, stroke risk but shares fall
FILE PHOTO – An Amgen sign is seen at the company’s office in South San Francisco, California, U.S. on October 21, 2013. REUTERS/Robert Galbraith/File Photo Amgen Inc’s (AMGN.O) $14,000 cholesterol drug Repatha cut the risk of heart attack and stroke by over 2... More »
